CNSX:VIDAPhivida Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Phivida Holdings Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.08 -0.01 (-11.11 %) (As of 05/29/2020 04:00 PM ET) Add Compare Share Today's Range$0.08Now: $0.08▼$0.0950-Day Range$0.06MA: $0.07▼$0.1052-Week Range N/AVolume42,950 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsHeadlines Phivida Holdings Inc., a functional food and beverage company, engages in purchasing, packaging, and selling holistic hemp infused remedies in the United States. The company offers hemp oil infused beverages under the OKI brand; and tinctures and capsules under the Vida + brand, as well as sells cannabis accessories. It also operates e-commerce platforms under the Greencamp, bloomgrove, and Wikala brand names. The company was formerly known as Phytofarms Holdings Inc. and changed its name to Phivida Holdings Inc. in January 2017. Phivida Holdings Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Phivida. Previous Next 2.3 Community Rank Outperform VotesPhivida has received 6 “outperform” votes. (Add your “outperform” vote.)Underperform VotesPhivida has received 7 “underperform” votes. (Add your “underperform” vote.)Community SentimentPhivida has received 53.85% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Phivida and other stocks. Vote “Outperform” if you believe VIDA will outperform the S&P 500 over the long term. Vote “Underperform” if you believe VIDA will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldPhivida does not currently pay a dividend.Dividend GrowthPhivida does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Phivida insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.46 out of 5 stars Industry, Sector and Symbol Stock Exchange CNSX Industry Drug Manufacturers—Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolCNSX:VIDA Previous Symbol CUSIPN/A CIKN/A Webphivida.com Phone844 744 6646Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable TSXV:VIDA Rates by TradingView Receive VIDA News and Ratings via Email Sign-up to receive the latest news and ratings for VIDA and its competitors with MarketBeat's FREE daily newsletter. Phivida (CNSX:VIDA) Frequently Asked Questions Has Phivida been receiving favorable news coverage? Headlines about VIDA stock have been trending somewhat negative on Sunday, InfoTrie Sentiment reports. The research firm identifies positive and negative press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Phivida earned a daily sentiment score of -1.0 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View the latest news aboutPhivida. Who are some of Phivida's key competitors? Some companies that are related to Phivida include AAC Technologies (ABSCF), Abattis Bioceuticals (ATT), AgraFlora Organics International (AGRA), AgraFlora Organics International (AGFAF), Avicanna (PDDPF), Benitec Biopharma (BLT), Biome Grow (BIOIF), Body and Mind (BAMM), Chardan Healthcare Acquisition (PHGE), Chemesis International (CSI), Cresco Labs (VLNCF), Decibel Cannabis (DBCCF), Eisai (SGIOF), Halo Labs (WSLFF) and Kissei Pharmaceutical (KSPHF). View all competitors. What other stocks do shareholders of Phivida own? Based on aggregate information from My MarketBeat watchlists, some companies that other Phivida investors own include Canopy Growth (CGC), Body and Mind (BAMM), Cresco Labs (CRLBF), Curaleaf (CURLF), CV Sciences (CVSI), EnWave (ENW), Flower One (FLOOF), iAnthus Capital (ITHUF), KushCo (KSHB) and MPX International (MPXOF). Who are Phivida's key executives? Phivida's management team includes the following people: Mr. David Moon, Interim CEO & DirectorMr. Carmelo Marrelli C.A., C.P.A., CPA, B.Comm., CA, CGA, ACIS, Chief Financial Officer (Age 49, Pay $61.46k)Mr. George Kovalyov, VP of Fin. (Age 35, Pay $175k)Mr. Graham Magee, VP of Operations & SalesMr. John David Belfontaine, VP of Corp. Devel. (Age 41) What is Phivida's stock symbol? Phivida trades on the CNSX under the ticker symbol "VIDA." How do I buy shares of Phivida? Shares of VIDA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Phivida's stock price today? One share of VIDA stock can currently be purchased for approximately $0.08. What is Phivida's official website? The official website for Phivida is phivida.com. How can I contact Phivida? The company can be reached via phone at 844 744 6646. This page was last updated on 5/31/2020 by MarketBeat.com Staff
